GeneDx Holdings Corp. (WGSWW)

The security is trading at a penny-level price of $0.0002, which is dangerously close to zero and suggests imminent delisting or total capital loss. Fundamentally, the company is in severe distress with negative profit margins of -17.6%, negative operating margins of -25.6%, and a return on equity of -30.4%. While revenue grew by 17.4% recently, the cash burn is evident with negative operating cash flow of -$9.3 million and free cash flow of only $3.6 million against nearly $168 million in debt. The balance sheet shows a precarious debt-to-equity ratio of 66.2%, indicating significant leverage relative to shareholder equity. There is no dividend history, and the lack of annual price data prevents any assessment of long-term trajectory. The recent news mentions a 'turnaround opportunity' and a surge in the warrant, but these are speculative reactions to a fundamentally broken business with no earnings power and a price structure that offers no margin of safety. This is a high-risk speculative play on a potential revival, not an investment.